Patent: 8,715,652
Summary for Patent: 8,715,652
| Title: | Immunoglobulin preparations having increased stability |
| Abstract: | The present invention relates to a protein preparation having increased stability, comprising a stabiliser selected from the group consisting of non-polar and basic amino acids and having a pH of 4.0 to 5.2. The invention further relates to a pharmaceutical composition and a method of stabilising protein preparations. |
| Inventor(s): | Reinhard Bolli, Gerhard Hodler, Regula Styger |
| Assignee: | CSL Behring AG |
| Application Number: | US10/579,357 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,715,652
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Csl Behring Ag | PRIVIGEN | immune globulin intravenous (human), 10% liquid | Injection | 125201 | July 26, 2007 | ⤷ Start Trial | 2024-11-17 |
| Csl Behring Ag | PRIVIGEN | immune globulin intravenous (human), 10% liquid | Injection | 125201 | October 2, 2009 | ⤷ Start Trial | 2024-11-17 |
| Csl Behring Ag | PRIVIGEN | immune globulin intravenous (human), 10% liquid | Injection | 125201 | February 7, 2013 | ⤷ Start Trial | 2024-11-17 |
| Csl Behring Ag | HIZENTRA | immune globulin subcutaneous (human), 20% liquid | Injection | 125350 | March 4, 2010 | ⤷ Start Trial | 2024-11-17 |
| Csl Behring Ag | HIZENTRA | immune globulin subcutaneous (human), 20% liquid | Injection | 125350 | April 13, 2023 | ⤷ Start Trial | 2024-11-17 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
